ABUSArbutus Biopharma Corporation
$4.18-2.7% 1Y
$4.18
$3.6752 weeks$5.20
Is the price fair?
What ABUS's price assumes
Arbutus Biopharma Corporation trades at 5.28× earnings against 18.6× for the median Biotechnology name, cheaper than its own group.
5.28
Trailing P/E · Biotechnology median 18.6 · cheaper than the typical name in its group
Details›
- Healthcare median P/E509 names
- 26.0
- Biotechnology median P/E244 names
- 18.6
- Market capitalisation
- $825M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.